291 related articles for article (PubMed ID: 25498415)
1. Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF).
Fuss J; Hellweg R; Van Caenegem E; Briken P; Stalla GK; T'Sjoen G; Auer MK
Eur Neuropsychopharmacol; 2015 Jan; 25(1):95-9. PubMed ID: 25498415
[TBL] [Abstract][Full Text] [Related]
2. Reduced serum concentrations of brain-derived neurotrophic factor (BDNF) in transsexual Brazilian men.
Fontanari AMV; Costa AB; Aguiar B; Tusset C; Andreazza T; Schneider M; da Rosa ED; Soll BMB; Schwarz K; da Silva DC; Borba AO; Mueller A; Massuda R; Lobato MIR
Neurosci Lett; 2016 Sep; 630():109-113. PubMed ID: 27473941
[TBL] [Abstract][Full Text] [Related]
3. On the quest for a biomechanism of transsexualism: is there a role for BDNF?
Fuss J; Biedermann SV; Stalla GK; Auer MK
J Psychiatr Res; 2013 Dec; 47(12):2015-7. PubMed ID: 24070909
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
Fontanari AM; Andreazza T; Costa ÂB; Salvador J; Koff WJ; Aguiar B; Ferrari P; Massuda R; Pedrini M; Silveira E; Belmonte-de-Abreu PS; Gama CS; Kauer-Sant'Anna M; Kapczinski F; Lobato MI
J Psychiatr Res; 2013 Oct; 47(10):1546-8. PubMed ID: 23702250
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery.
Schneider MA; Andreazza T; Fontanari AM; Costa AB; Silva DC; Aguiar BW; Massuda R; Pedrini M; Gama CS; Schwarz K; Kauer-Sant'Anna M; Lobato MI
Trends Psychiatry Psychother; 2017; 39(1):43-47. PubMed ID: 28403322
[TBL] [Abstract][Full Text] [Related]
6. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
7. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
8. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.
Nota NM; Dekker MJHJ; Klaver M; Wiepjes CM; van Trotsenburg MA; Heijboer AC; den Heijer M
Andrologia; 2017 Aug; 49(6):. PubMed ID: 27561756
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor (BDNF) is not regulated by testosterone in transmen.
Auer MK; Hellweg R; Briken P; Stalla GK; T'Sjoen G; Fuss J
Biol Sex Differ; 2016; 7():1. PubMed ID: 26753091
[TBL] [Abstract][Full Text] [Related]
10. BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria.
Costa AB; Fontanari AM; Andreazza T; Salvador J; Koff WJ; Aguiar B; Ferrari P; Massuda R; Pedrini M; Silveira E; Belmonte-de-Abreu PS; Gama CS; Kauer-Sant'Anna M; Kapczinski F; Lobato MI
J Psychiatr Res; 2014 Mar; 50():16-7. PubMed ID: 24332481
[No Abstract] [Full Text] [Related]
11. Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study.
Colizzi M; Costa R; Todarello O
Psychoneuroendocrinology; 2014 Jan; 39():65-73. PubMed ID: 24275005
[TBL] [Abstract][Full Text] [Related]
12. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
13. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety.
Molendijk ML; Bus BA; Spinhoven P; Penninx BW; Prickaerts J; Oude Voshaar RC; Elzinga BM
World J Biol Psychiatry; 2012 Oct; 13(7):535-43. PubMed ID: 21888560
[TBL] [Abstract][Full Text] [Related]
14. Hormone treatment of the adult transsexual patient.
Gooren L
Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
[TBL] [Abstract][Full Text] [Related]
15. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual.
García-Malpartida K; Martín-Gorgojo A; Rocha M; Gómez-Balaguer M; Hernández-Mijares A
Fertil Steril; 2010 Aug; 94(3):1097.e13-5. PubMed ID: 20227072
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons.
Yahyaoui R; Esteva I; Haro-Mora JJ; Almaraz MC; Morcillo S; Rojo-Martínez G; Martínez J; Gómez-Zumaquero JM; González I; Hernando V; Soriguer F
J Clin Endocrinol Metab; 2008 Jun; 93(6):2230-3. PubMed ID: 18349066
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
[TBL] [Abstract][Full Text] [Related]
18. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
Gooren L; Lips P
J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
[TBL] [Abstract][Full Text] [Related]
19. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
[TBL] [Abstract][Full Text] [Related]
20. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia.
Quirós C; Patrascioiu I; Mora M; Aranda GB; Hanzu FA; Gómez-Gil E; Godás T; Halperin I
Endocrinol Nutr; 2015 May; 62(5):210-6. PubMed ID: 25790747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
